The Journal of Organic Chemistry
Page 10 of 11
1
2
3
added formaldehyde (38% CH2O in water, 61 μL, 0.84 mmol, 300 mol-
1H), 7.57 (s, 1H), 7.32 – 7.24 (m, 5H), 7.17 (app. d, J = 8.3 Hz, 2H),
%) at rt. The reaction mixture was stirred at rt for 15 min after which
NaBH(OAc)3 (237 mg, 1.12 mmol, 400 mol-%) was added in one
portion. The reaction mixture was stirred at rt for 4 h before sat. aq.
NaHCO3 (18 mL) was added. The mixture was allowed to stir for 15
min, and then the layers were separated. The aqueous layer was washed
with DCM (3 × 18 mL). The combined organic extracts were dried
over Na2SO4 and concentrated. Purification of the residue by flash
chromatography (4% 7N NH3/MeOH in DCM) afforded the desired
product 2 as a pale crystalline solid (133 mg, 64%). Characterization
data are in full agreement with our previous publication.7c 1H NMR
(500 MHz, CD2Cl2): δ 9.40 (b rs, 1H), 8.71 (s, 1H), 8.61 (s, 1H), 8.20
(s, 2H), 7.53 (s, 1H), 7.33 – 7-28 (m, 4H), 7.26 (dd, J = 8.4, 1.4 Hz,
1H ), 7.09 (d, J = 8.4 Hz, 1H), 6.65 (s, 1H), 6.34 (brs, 1H), 4.46 (app.
q, J = 8.1 Hz, 1H), 3.65 (dd, J = 14.6, 6.9 Hz, 1H), 3.49 (brs, 1H), 3.29
(dd, J = 14.6, 9.1 Hz, 1H), 2.31 (m, 1H), 2.21 (m, 1H), 1.93 (brs, 6H),
1.79 (m, 1H), 1.75 (m, 1H), 1.64 (brs, 1H), 1.27 (m, 1H), 1.16 – 1.12
(m, 3H); 13C{1H} NMR (75 MHz, CD2Cl2): δ 183.5, 152.6, 150.0,
141.8, 138.5, 138.1, 132.3 (q, J = 33.1 Hz), 129.2, 128.2, 125.8, 124.9
(q, J = 271.5 Hz), 124.9 (q, J = 31.7 Hz), 123.9 (q, J = 272.7 Hz),
119.5, 118.4, 115.7 (sept, J = 4.0 Hz), 115.4, 114.2, 90.9, 67.8, 65.6,
57.0, 40.1, 37.4, 33.8, 24.8 (2C), 22.6.
1-(3,5-bis(trifluoromethyl)phenyl)-3-(2-(((1R,2R)-1-(3-((1S,2S)-
2-(dimethylamino)cyclohexyl)thioureido)-2,3-dihydro-1H-inden-2-
yl)oxy)-5-(trifluoromethyl)phenyl)urea (1). The reaction was
performed using 7 (187 mg, 0.28 mmol, 100 mol-%) utilizing the
procedure used for the preparation of 2. The product was purified by
flash chromatography (4% 7N NH3/MeOH in DCM) to afford 1 as a
pale crystalline solid (145 mg, 75%). Characterization data are in full
agreement with our previous publication.7c 1H NMR (500 MHz,
CD2Cl2): δ 9.61 (br s, 1H), 8.71 (s, 1H), 8.46 (s, 1H), 8.21 (s, 2H),
7.53 (s, 1H), 7.34 (m, 3H), 7.27 (d, J = 8.2 Hz, 2H), 7.09 (d, J = 8.4
Hz, 1H), 6.65 (brs, 1H), 6.00 (brs, 1H), 4.47 (app. q, J = 7.5 Hz, 1H),
3.65 (dd, J = 15.3, 7.6 Hz, 1H), 3.27 (app. dd, J = 15.3, 8.8 Hz, 2H),
2.34 (app. td, J = 10.5, 3.5 Hz, 1H), 2.02 (s, 6H), 1.79 (app. d, J = 11.2
Hz, 1H), 1.69 (m, 2H), 1.62 (m, 1H), 1.17 (m, 1H), 1.09 – 1.01 (m,
3H); 13C{1H} NMR (125 MHz, CD2Cl2): δ 184.3, 152.5, 150.0, 141.7,
138.4, 138.1, 132.3 (q, J = 33.1 Hz), 131.4, 129.2, 128.0, 125.8, 124.8
(q, J = 271.6 Hz), 124.8 (q, J = 32.4 Hz), 123.9 (q, J = 272.6 Hz),
123.3, 119.4 (app. q, J = 4.0 Hz), 118.4 (app. d, J = 3.0 Hz), 115.8
(quint, J = 3.9 Hz), 115.5, 114.7, 91.8, 68.3, 65.9, 57.2, 40.2, 37.5, 33.8,
24.8, 24.7, 22.5.
Typical Procedure for the Preparation of HCl Salts of Catalysts 1
and 2. To a solution of catalyst (10 mg, 0.013 mmol, 100 mol-%) in
DCM (2 mL) was added aq. HCl (conc., 53 μL, 0.65 mmol, 5000 mol-
%) at 0 °C. A white precipitate was immediately formed and the
mixture was stirred for 5 min at rt. The solvent and the excess of HCl
were removed carefully under reduced pressure.
All other Catalyst HX salts were prepared in an analogous manner
except that for non-volatile acids, 110 mol-% of the corresponding acid
was used. The crystalline salts were grown using diffusion method from
a binary solvent mixture consisting of either cyclopentane, benzene or
toluene (1st component) and dichloromethane (2nd component).
Note: The 2D NOESY spectrum of both HCl salts were measured
with 500 MHz spectrometer at 30 °C (303 K). Both salts show some
instability after 24 hours in CD3CN. ent-1·HCl salt is only sparingly
soluble in CD3CN and as such the NMR sample was warmed up to 70
°C before the start of the measurement and then recooled to the probe
temperature (303 K).
6.48 (t, J = 8.2 Hz, 1H), 5.29 (brs, 1H), 4.93 (brs, 1H), 3.63 (m, 2H),
2.83 (m, 1H), 2.78 (s, 3H), 2.77 (s, 3H), 2.24 (m, 1H), 2.08 (m, 1H),
1.90 (m, 1H), 1.80 (m, 1H), 1.59 – 1.49 (m, 2H), 1.41 – 1.26 (m, 2H);
13C{1H} NMR (125 MHz, CD3CN): 182.8, 153.7, 149.3, 143.1, 140.1,
138.6, 132.4 (q, J = 32.9 Hz), 131.0, 129.6, 128.9, 128.7, 128.5, 128.4,
125.7 (q, J = 271.9), 126.3, 124.6, 124.5 (q, J = 272.0 Hz), 123.4 (q, J =
33.9 Hz) 119.9, 115.6, 112.6, 110.9, 84.2, 67.2, 63.2, 56.2, 42.9, 37.4,
36.2, 32.8, 25.1, 24.7, 23.3.
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(1R,2R)-2-(3-((1S,2S)-2-(2-(3-(3,5-
bis(trifluoromethyl)phenyl)ureido)-4-(trifluoromethyl)phenoxy)-2,3-
dihydro-1H-inden-1-yl)thioureido)-N,N-dimethylcyclohexan-1-
aminium chloride (ent-1 HCl)
1H NMR (500 MHz, CD3CN): 11.20 (s, 1H), 9.39 (s, 1H), 8.68 (s,
1H), 8.20 (s, 3H), 7.90 (br s, 1H), 7.59 (s, 1H), 7.38 – 7.28 (m, 4H),
7.24 (m, 1H), 6.78 (br s, 1H), 5.24 (m, 1H), 4.80 (m, 1H), 3.98 (m,
1H), 3.60 (dd, J1 = 15.5, 7.1 Hz, 1H), 2.90 (d, J = 3.7 Hz, 3H), 2.83 (m,
1H), 2.79 (d, J = 4.3 Hz, 3H), 1.88 (m, 1H), 1.65 (app. d, J = 11.9 Hz,
1H), 1.47 (m, 1H), 1.42 (m, 1H), 1.26 – 1.12 (m, 3H), 0.75 (m, 1H);
13C{1H} NMR (125 MHz, CD3CN): 183.1, 153.7, 149.0, 143.0, 139.5,
139.0, 132.6 (q, J = 32.9 Hz), 131.0, 129.9, 128.5, 126.2, 125.6 (q, J =
270.2 Hz), 125.1, 124.5 (q, J = 271.9 Hz,), 123.7 (q, J = 32.2 Hz),
120.1, 116.0, 115.7, 113.1, 110.9, 87.5, 67.4, 63.2, 56.1, 42.8, 37.8, 36.5,
32.9, 24.9, 24.7, 23.1.
Catalyst Solution Structure Elucidation. Catalyst 1 solution struc-
ture: The sample was prepared by dissolving catalyst 1 (10 mg, 0.0134
mmol, 100 mol %) in 0.6 mL DCM-d2. The 2D NOESY spectrum was
measured with 500 MHz spectrometer at 303 K. Catalyst 2 solution
structure: The sample was prepared by dissolving catalyst 2 (10 mg,
0.0134 mmol, 100 mol %) in 0.6 mL DCM-d2. The 2D NOESY spec-
trum was measured with 500 MHz spectrometer at 303 K.
Solution Structures of Catalysts Hexafluoroacetylacetonate salts.
The sample of catalyst 1 hfacac salt was prepared by dissolving catalyst
1 (10 mg, 0.0134 mmol, 100 mol %) in 0.6 mL DCM-d2 and hfacac
(1.9 μL, 0.0134 mmol, 100 mol %) was subsequently added. The 2D
NOESY spectrum was measured with 500 MHz spectrometer at 303 K.
The sample of catalyst 2 hfacac salt was prepared by using the
procedure used for the 1·hfacac salt. The 2D NOESY spectrum was
measured with 300 MHz spectrometer at 303 K.
Titration experiments. Titration of catalyst 1·hfacac with tetra-n-
butylammonium chloride (n-Bu4NCl): Catalyst 1 (11.2 mg, 0.015
mmol, 100 mol %) was dissolved in CD3CN (0.6 mL), hfacac (2.1 μL,
0.015 mmol, 100 mol %) was subsequently added and transferred to
NMR tube. This solution was titrated with 0.5M solution of n-Bu4NCl
1
in CD3CN. H NMR (300 MHz) measurement was performed every
30 minutes after the addition of n-Bu4NCl, insertion of the sample into
the magnet, and initial shimming and receiver gain adjustment. All
measurements were carried out at a probe temperature 303 K.
ASSOCIATED CONTENT
Supporting Information: Details of the X-ray structural
characterization, and computational details: total energies and
Cartesian coordinates for the considered stationary points. This
material is available free of charge via the Internet at
AUTHOR INFORMATION
Corresponding Author
*Petri.Pihko@jyu.fi
(1R,2R)-2-(3-((1R,2R)-2-(2-(3-(3,5-
bis(trifluoromethyl)phenyl)ureido)-4-(trifluoromethyl)phenoxy)-2,3-
dihydro-1H-inden-1-yl)thioureido)-N,N-dimethylcyclohexan-1-
aminium chloride (2 HCl). 1H NMR (500 MHz, CD3CN): δ 11.10 (s,
1H), 9.28 (brs, 1H), 9.15 (s, 1H), 8.74 (s, 1H), 8.21 (s, 2H), 7.61 (br s,
ACKNOWLEDGMENT
ACS Paragon Plus Environment